Director, Bioinformatics at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

PhD in computational biology, computer science, data science, physical science, statistics, or a related field with a minimum of 10+ years of relevant work experience, including extensive experience leading computational biology and data science initiatives in the biopharma industry
Extensive scientific and technical experience driving excellence and innovation with high standards for impactful deliverables and achievements
Lead team efforts to provide capabilities and deliver solutions, and collaborate cross-functionally to derive scientific insights and inform decisions from large-scale complex data
Recognized domain expert in computational biology, data science areas and proactively assess cutting-edge technologies and evolutions in the relevant fields, including but not limited to single-cell and spatial omics, human genetics, functional genomics, etc. Applies in-depth knowledge to practical problem solving with result-driven mindset
Trusted partner and advisor for cross-functional teams on the necessary direction to achieve data science goals and objectives with impact across multiple functions. Proactively seeks out key business challenges and provides leadership advice and guidance on new solution development and execution
Develops and cultivates strong and enduring relationships with external thought leaders. Identifies and recommends future-facing change opportunities that advance and accelerate

Responsibilities

Lead statistical and bioinformatics analysis of multi-omics datasets (transcriptomic, single cell sequencing, human genetics, high throughput screening, etc.) to support target discovery, pipeline programs and translational research
Develop novel analysis of large omics and high dimensional data from internal, publicly available, commercial, and real-world datasets to enable target identification/assessment, drug combinations, understanding of MOA, disease mechanisms, biomarker identification, etc
Initiate and lead external collaborations with academic and industry partners to build data resources, drive technological innovations and deliver high impact results
Collaborate with cross-functional teams to analyze and interpret complex large datasets, communicate findings and recommend follow-up actions

Skills

Bioinformatics

Computational Biology

AI/ML

Statistical Analysis

Multi-omics

Transcriptomics

Single Cell Sequencing

Human Genetics

High Throughput Screening

Target Discovery

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free